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1. Introduction 
Cellular drug responses are the most fundamental reactions in biology and medicine, which 
provides valuable information for understanding the fundamental mechanisms of biology and 
the development of new drugs. To investigate the drug responses efficiently and massively, 
high-throughput screening has played a major role over the past decades. This technique is 
powerful in exploring a large number of samples, but is often limited by the fact that it only 
acquires a single variate from each sample, for example, live or dead. Owing to the 
technological advances of imaging and robotics, image-based high-throughput screening, 
namely high-content screening, has been developed to acquire a significantly larger number 
of variables in each sample to capture more information in the cellular drug responses. Such 
a multivariate image-based technique has been proven effective in a broad spectrum of 
quantitative analysis not simply in drug responses but also associated with genome and 
proteome analysis. 
Despite the utility of image-based screening, it falls short in addressing the full needs of 
biological applications as it inherently requires fluorescent labeling which has several 
drawbacks. First, fluorescent probes are not available for all target molecules and may 
interfere with natural cellular functions. Although a wide range of immunofluorescent probes 
are commercially available for cellular imaging, they are costly and require time-consuming 
labeling processes including cell fixation which kills the cells, and thus hinders live-cell and 
large-scale assays. In addition, while fluorescently tagged cell lines can offer live-cell assays 
without such a labeling process, the development of such cell lines requires even more efforts 
than immunofluorescent labeling. Therefore, a method for image-based high-content 
screening without using fluorophores is desired for easy manipulation and economical assays. 
In my doctoral work, I studied cellular drug responses in a label-free manner by high-
throughput bright-field imaging with the aid of machine-learning techniques in various 
settings. The first chapter introduce the background of cellular drug responses, high 
throughput screening, thigh content screening and high-speed imaging modalities. Chapter 2 
discusses the principles of the major components that were employed in my study including 
optofluidic time-stretch (OTS) microscopy, microfluidic design, image processing and 
machine learning. Chapter 3 describes the experimental demonstration of distinguishing 
cellular drug responses through morphological changes as a proof-of-concept. Specifically, I 
treated MCF-7, a human breast cancer cell with different concentrations of paclitaxel, a 
conventional anticancer drug to induce morphological changes on cells. While those 
morphological changes are too subtle to be observed by human eyes, they were consistently 
detected on images through the method I developed in my thesis. Chapter 4 describes a 
challenging application of label-free detection of drug responses with whole blood. In this 
chapter, K562, a chronic myeloid leukemia cell line, and its drug resistant strain K562/ADM 
were treated with adriamycin, another conventional anticancer drug. which drug responses of 
cancer cells were evaluated as they were spiked in undiluted blood. The drug treated cells were 
further spiked into whole blood to mimic a practical situation in blood diagnosis, and their 
morphological changes were successfully captured by our system. Chapter 5 describes another 
challenging application where the drug responses of cancer cells harvested from mouse 
xenografts were evaluated. In this chapter, A549/EGFP and PC-9/mRuby (two lung cancer 
cell lines into which fluorescence proteins, mEGFP and mRuby2 were genetically inserted 
respectively) were generated to discriminate them from somatic murine cells. These cells were 
transplanted into athymic nude mice, and harvested after grown. The collected cells were 
further treated with gefitinib, an anticancer drug as targeted medicine for the evaluation of 
drug responses. Finally, chapter 6 discusses the advantages and limitations in label-free 
detection of drug responses as well as possible future work.  
 
2. Label-free detection of drug responses of cancer cells: experimental 
demonstration (Chapter 3) 
The workflow for label-free detection of morphological changes is schematically illustrated 
in Fig. 1. The whole process can be divided into four parts: (1) drug treatment, (2) optofluidic 
time-stretch imaging, (3) feature extraction, and (4) classification. In this study, I used MCF-
7, a human breast adenocarcinoma cell line, as a model cell, and paclitaxel, a classic anti-
cancer drug, as a model drug to induce morphological changes to the cells. In order to acquire 
high-quality bright-field images of the cells in a high-throughput manner, OTS microscopy 
was employed. OTS microscopy is a high-speed imaging flow cytometry technique in which 
cells are scanned by spatially mapped broadband optical pulses while they are flowing in a 
 
Figure 1. Workflow. Drug-treated and -untreated cells were imaged by the optofluidic time-stretch 
microscope. Then, the morphological features were extracted from the acquired images, based on which the 
two types of cells were classified into two groups. 
microfluidic channel. My group has 
previously developed an OTS microscope 
with a spatial resolution of 780 nm and a 
flow speed of approximately 1 m/s. 
However, the 1-m/s flow speed of the 
microfluidic channel had been limited the 
throughput of the system, hindering its 
application in the measurement of a large 
number of cells. By optimizing the structure 
and design of the microfluidic channel, I 
successfully increased the flow speed by a 
factor of 10, achieving 10 m/s to enable 
higher throughput without sacrificing spatial 
resolution. Each blur-free image acquired 
with the OTS microscope shown in Fig. 2 
was obtained in as short as 4 µs, which 
corresponded to a frame rate of 250,000 
frames per second. Those images acquired 
by the OTS microscope maintain the same 
pixel resolution as the static images 
acquired by a CMOS camera on a 
conventional microscope. 
To evaluate whether the drug induced 
morphological changes on cells can be 
detected with the proposed approach, 
MCF-7 cells treated with various 
concentrations of paclitaxel were examined 
following the workflow shown in Fig. 1. A 
total number of 548 features were extracted 
from each image by using CellProfiler, an 
open source image analysis software, and 
then support vector machine (SVM) 
classificatio was implemented on 
MATLAB. Figure 3 shows the 
distributions of drug-treated and -untreated 
(negative control) populations after 
classification in various concentrations. 
The separation between these two 
populations increases along with drug 
concentrations up to 1 µM. This trend was constantly observed in two replicates of 
experiments and four trials of SVM classification. This result indicates that the morphological 
changes due to drug treatment can be perceived through label-free bright-field imaging and 
machine learning based classification. The result also suggests that the morphological changes 
are dependent on drug concentration, which is investigated in the following paragraph. 
 
3. Label-free detection of drug responses of cancer cells in human whole 
blood (Chapter 4) 
With the successful demonstration of cellular drug responses expressed in morphological 
changes, I further investigated the feasibility of evaluating cellular drug responses in a more 
 
Figure 2. Images of drug-treated and -untreated 
MCF-7 cells. The top row shows the images 
acquired by the OTS microscope in which cells were 
flowing at a speed of 10 m/s. The right column 
shows the images of MCF7 cells treated with 
paclitaxel for 24 hours. Scale bar: 10 µm. 
 
Figure 3. Classification of drug-treated and -untreated 
cells. Histogram of SVM classification scores for 
MCF-7 cells treated with various concentrations of 
paclitaxel for 24 hours. Each population consists of 
up to 10,000 cells. 
practical situation such as using whole blood. In this chapter, I demonstrate an improved 
microfluidic channel which enables cells flow at 15 m/s, and increasing the throughput more 
than one million cells per second. I also demonstrate the classification of drug treated and 
untreated cells with K562 and K562/ADM, a chronic myeloid leukemia cell line and its drug 
resistant strain, and adriamycin, an anticancer drug often used for leukemia. Furthermore, I 
spiked the drug treated K562 and K562/ADM in whole blood and clearly captured the images 
of these cells along with other blood cells at the throughput of 106 cells/s (Figure 4). Their 
dose dependent drug responses were identified from these images suggesting that the method 
I developed in this thesis can be applied to evaluate the drug responses as a blood diagnosis. 
 
4. Label-free detection of drug responses of ex vivo cancer cells in mice 
(Chapter 5) 
In this chapter, I examined the feasibility of using dissociated xenograft as target cells to 
investigate their drug responses through my method. For this purpose, A549/EGFP and PC-
9/mRuby (two lung cancer cell lines into which fluorescence proteins, mEGFP and mRuby2 
were genetically inserted respectively) were generated to discriminate them from somatic 
murine cells. These cells were transplanted into athymic nude mice, and harvested after 
grown. The collected cells were further treated with gefitinib, an anticancer drug as targeted 
medicine for the evaluation of drug responses. The drug responses of A549/EGFP and PC-
9/mRuby were also tested without transplanted in mice, which means they were tested with 
identical processes as I discussed in previous chapters. Both in vitro and ex vivo results 
showed differences in drug response, suggesting my method can also applicable to evaluate 
the drug responses of ex vivo samples.  
 
 
Figure 4. K562 and 
K562/ADM cells spiked 
in whole blood were 
clearly captured in the 
flow. More than 20 cells 
can be seen in each frame 
which was acquired in 20 
µs resulting in a 
throughput of over 106 
cells/s.  Flow speed: 15 
m/s, scale bar: 10 µm. 
 
